Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver

By Wörns Marcus A.   Bosslet Timon   Victor Anja   Koch Sandra   Hoppe-Lotichius Maria   Heise Michael   Hansen Torsten   Pitton Michael B.   Niederle Ina M.   Schuchmann Marcus   Weinmann Arndt   Düber Christoph   Galle Peter R.   Otto Gerd  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 6, 2012-06 ,pp. : 718-728

Informa Healthcare

Access to resources Recommend Favorite

Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis

By Teuber G.   Teupe C.   Dietrich C.F.   Caspary W.F.   Buhl R.   Zeuzem S.  

European Journal of Internal Medicine, Vol. 13, Iss. 5, 2002-08 ,pp. : 311-318

Elsevier

Access to resources Recommend Favorite

Therapeutic Management Algorithm in Cirrhotic and Noncirrhotic Patients in Primary or Secondary Liver Masses

By Frezza Eldo Ermenegildo  

Digestive Diseases and Sciences, Vol. 49, Iss. 5, 2004-05 ,pp. : 866-871

Springer Publishing Company

Access to resources Recommend Favorite

VERY LOW DOSES OF UNFRACTIONATED HEPARIN POTENTIATE THE ANTI-Xa ACTIVITY OF LOW MOLECULAR WEIGHT HEPARIN (ENOXAPARIN)

By Perez-Requejo J.L.   Lucena-Solano O.   Perez-Garcia M.   Santarelli M.T.  

Thrombosis Research, Vol. 85, Iss. 3, 1997-02 ,pp. : 259-265

Elsevier

Access to resources Recommend Favorite

Dextran sulfate included in factor Xa assay reagent overestimates heparin activity in patients after heparin reversal by protamine

By Mouton C.   Calderon J.   Janvier G.   Vergnes M.-C.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 273-279

Elsevier

Access to resources Recommend Favorite